DiaMedica Therapeutics Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On and effective March 9, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Lewis as a member of the Compensation Committee of the Board.
the Board of Directors (the “Board”) of the Company appointed Tanya N. Lewis to the Board, effective March 1, 2023.
Extracted from this filing and checked against the source text.
Tanya N. Lewis was appointed as Member of Compensation Committee at DiaMedica Therapeutics Inc..
On and effective March 9, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Lewis as a member of the Compensation Committee of the Board.View on SEC.gov
Tanya N. Lewis was appointed as Director at DiaMedica Therapeutics Inc..
the Board of Directors (the “Board”) of the Company appointed Tanya N. Lewis to the Board, effective March 1, 2023.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.